Butterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer – POCUS

Prominent POCUS thought leader joins to advance clinical strategy and further Butterfly’s mission to democratize ultrasound worldwide.

BURLINGTON, Mass. & NEW YORK–(BUSINESS WIRE)–$BFLY #POCUSButterfly Network (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Arun Nagdev, MD as Chief Medical Officer – Point-of-Care Ultrasound (POCUS). In this role, Dr. Nagdev will lead the global medical strategy for the Company’s core POCUS business, advancing clinical product validation, strengthening customer engagement, and supporting regulatory and clinical development efforts.

Primary Logo Colorized Black word mark
Primary Logo Colorized Black word mark

Dr. Nagdev brings more than 20 years of experience advancing POCUS adoption, education, and clinical standards worldwide. He currently serves as an attending physician and Director of Emergency Ultrasound at Highland General Hospital and as an Associate Clinical Professor of Emergency Medicine at University of California, San Francisco. He has also held national leadership roles within leading professional organizations, including the American College of Emergency Physicians and the American Institute of Ultrasound in Medicine.

In addition to his clinical and academic leadership, Dr. Nagdev brings deep experience at the intersection of ultrasound, artificial intelligence, and product development. He previously served as Vice President of Clinical at Exo and has advised global imaging companies including Philips and Fujifilm SonoSite. He is also a widely published researcher and educator, with an influential body of peer-reviewed research and invited presentations worldwide.

Arun is one of the most respected voices in point-of-care ultrasound, with a rare combination of clinical credibility, academic leadership, and product insight,” said Joseph DeVivo, President, CEO, and Chairman of Butterfly Network. “As we continue to scale our enterprise strategy and expand globally, his leadership will be critical to ensuring our technology delivers measurable clinical and economic value for customers.”

Butterfly has fundamentally changed what’s possible with ultrasound through its semiconductor-based, software-defined platform,” said Dr. Nagdev. “I’m excited to join at a time when point-of-care ultrasound is becoming essential to care delivery across settings. The next phase will be defined by clinical standards and broader adoption, and I look forward to supporting that progression globally.”

About Butterfly Network

Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly’s innovations have also been recognized by Fierce 50, TIME’s Best Inventions and Fast Company’s World Changing Ideas, among other achievements.

Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: https://www.butterflynetwork.com/choose-your-country.

Contacts

Media:
Liz Learned Snyder

Director, Comms & PR, Butterfly Network

[email protected]

Investors:
John Doherty

Chief Financial Officer

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.